Menu
Enrolling by invitation NCT06101979

A Prospective Study of Fortiva in Hernia Repair

Observational Ventral Hernia Incisional Hernia Abdominal Wall Reconstruction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Fortiva Tissue Matrix.
Who it may be relevant to
Registry conditions: Ventral Hernia, Incisional Hernia, Abdominal Wall Reconstruction. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this study is to evaluate safety and performance of the Fortiva Tissue Matrix. Participants will complete questionnaires to measure outcomes after hernia surgery for two years.

Detailed description

This is a post market, prospective, multi-center study of up to 120 participants at approximately 10 clinical study sites. Safety and performance will be measured after hernia repair for two years.

Interventions

  • Device Fortiva Tissue Matrix
    Acellular Dermal Matrix used in hernia surgery

Primary outcome measures

  • Type of adverse events [Time frame: 6 weeks, 6 months, 12 months and 24 months]
Secondary outcome measures (4)
  • Patient satisfaction [Time frame: 6 weeks, 6 months, 12 months and 24 months]
  • Pain measured using the visual analog scale for pain [Time frame: 6 weeks, 6 months, 12 months and 24 months]
  • Implant failure [Time frame: 6 weeks, 6 months, 12 months and 24 months]
  • Hernia recurrence [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • 18 years of age at time of consent
  • Undergoing hernia surgery in which Fortiva Tissue Matrix will be used
  • Have no contraindications to the test material (s)
  • Able to provide informed consent
  • Able to read, understand and complete study questionnaires
  • Able and willing to return for scheduled study visits

Exclusion criteria

  • <18 years of age
  • American Society of Anesthesiologists (ASA) physical class of 4,5 or 6
  • Currently enrolled or plans to enroll in another clinical study that would affect the validity of the study
  • Hernia repairs involving active infection

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United Kingdom · 1 center
  • James Paget University Hospital — Great Yarmouth

Identifiers

NCT: NCT06101979 · RTI-2022-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗